This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.?
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Dieter Marmé is renowned for his scientific work on molecular biology and tumor biology, and in particular for research into the roles of growth factors in the mechanisms by which tumor angiogenesis is initiated and propagated. At the time of his retirement in 2005, he had spent more than two decades at the Tumor Biology Center in Freiburg, Germany. He initially joined the Center as Director of the Institute of Molecular Medicine in 1993 and later served as its Director of Research and Chairman of the Board of Directors. Prior to joining the Tumor Biology Center, Dr. Marmé had been an Extraordinary Professor in the Department of Genetics and Molecular Biology at the University of Freiburg and had then spent a decade working for Gödecke, a division of Parke-Davis (now Pfizer), initially as Head of Pharmacological Biochemistry and later as Head of Biological Research. Based on the understanding of the mechanisms by which tumors progress and tumor angiogenesis is initiated, he focused on the investigation of therapeutic concepts to interfere with the development of malignancies. After retiring from the Tumor Biology Center in 2005, he continued to work for the institution as an Adviser in Oncology and at the same time became a member of the editorial board for various journals in the field of oncology and a consultant for pharmaceutical companies. Dr. Marmé is the coeditor of the previous Springer book Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy (2008).
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
Condizione: new. Questo è un articolo print on demand. Codice articolo 08d76400cddef4b664a0a947d0020c51
Quantità: Più di 20 disponibili
Da: moluna, Greven, Germania
Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Explains the mechanisms of tumor angiogenesisDocuments clinical applications of anti-angiogenic treatments for a large variety of tumorsExamines combination of anti-angiogenic treatment with other targeted and/or cytotoxic cancer therapies. Codice articolo 119492040
Quantità: Più di 20 disponibili
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented. 704 pp. Englisch. Codice articolo 9783319336718
Quantità: 2 disponibili
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.¿Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 704 pp. Englisch. Codice articolo 9783319336718
Quantità: 1 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented. Codice articolo 9783319336718
Quantità: 1 disponibili
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented. This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9783319336718
Quantità: 1 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Hardcover. Condizione: Brand New. 681 pages. 9.25x6.10x1.34 inches. In Stock. Codice articolo x-3319336711
Quantità: 1 disponibili